Hester Biosciences Stock Screener | Share Price & Fundamental Analysis
HESTERBIO
Pharmaceuticals
Share Price NSE
₹1572.30
▲
0.50 (0.03%)
Share Price BSE
₹1560.40
▼
-1.75 (-0.11%)
Track Hester Biosciences share price live with TickJournal's free stock screener.
Analyze Hester Biosciences share price history trends and compare 52-week high low
levels.
Calculate HESTERBIO stock fair value using fundamental analysis and view live share price charts.
Determine Hester Biosciences share intrinsic value and compare it with current HESTERBIO share price.
Record your Hester Biosciences trades in TickJournal's free trading journal and track your portfolio performance.
Hester Biosciences Market Cap
₹1,336.00 Cr.
EPS (TTM)
₹33.89
Dividend Yield
0.45%
Debt to Equity
0.76
HESTERBIO 52 Week High
₹2193.80
Hester Biosciences 52 Week Low
₹1254.50
Operating Margin
23.00%
Profit Margin
2.63%
HESTERBIO Revenue (TTM)
₹76.00
EBITDA
₹14.00
Net Income
₹2.00
Total Assets
₹653.00
Total Equity
₹327.00
Hester Biosciences Share Price History - Stock Screener Chart
Screen HESTERBIO historical share price movements with interactive charts. Analyze price trends and patterns.
Hester Biosciences Company Profile - Fundamental Screener
Screen Hester Biosciences company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for HESTERBIO shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE782E01017
Hester Biosciences Balance Sheet Screener
Screen HESTERBIO balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 653 | 662 | 670 | 562 | 411 | 387 | 300 | 244 | 213 | 186 |
| Current Assets | 195 | 215 | 228 | 195 | 162 | 159 | 143 | 98 | 80 | 74 |
| Fixed Assets | 233 | 240 | 259 | 237 | 133 | 142 | 145 | 110 | 103 | 65 |
| Liabilities | ||||||||||
| Total Liabilities | 653 | 662 | 670 | 562 | 411 | 387 | 300 | 244 | 213 | 186 |
| Current Liabilities | 202 | 254 | 233 | 198 | 114 | 97 | 70 | 44 | 48 | 41 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 327 | 303 | 289 | 267 | 236 | 207 | 181 | 145 | 127 | 106 |
| Share Capital | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 |
| Reserves & Surplus | 306 | 283 | 271 | 252 | 220 | 193 | 169 | 132 | 113 | 93 |
Hester Biosciences Income Statement Screener - Profit & Revenue Analysis
Screen Hester Biosciences income statement and profit fundamentals.
Analyze HESTERBIO quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Hester Biosciences share price evaluation.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec | 2022-Mar | 2022-Jun | 2022-Sept |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 76 | 88 | 83 | 79 | 84 | 84 | 87 | 72 | 71 | 90 | 76 | 69 | 64 | 55 | 78 |
| Expenses | 63 | 61 | 59 | 60 | 63 | 65 | 65 | 58 | 56 | 74 | 57 | 57 | 46 | 43 | 60 |
| EBITDA | 14 | 26 | 24 | 20 | 21 | 20 | 22 | 14 | 15 | 17 | 19 | 12 | 18 | 12 | 18 |
| Operating Profit % | 23.00% | 27.00% | 17.00% | 23.00% | 20.00% | 21.00% | 23.00% | 8.00% | 17.00% | 16.00% | 19.00% | 15.00% | 18.00% | 15.00% | 17.00% |
| Depreciation | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 5 | 5 | 4 | 4 | 5 | 5 | 5 |
| Interest | 6 | 2 | 2 | 2 | 7 | 5 | 6 | -4 | 1 | 3 | 8 | 2 | 2 | 2 | 3 |
| Profit Before Tax | 4 | 20 | 17 | 14 | 10 | 11 | 12 | 13 | 8 | 9 | 7 | 6 | 11 | 6 | 10 |
| Tax | 2 | 3 | 3 | 4 | 4 | 3 | 4 | 2 | 3 | 2 | 3 | 2 | 2 | 2 | 4 |
| Net Profit | 2 | 17 | 14 | 9 | 6 | 8 | 8 | 11 | 6 | 7 | 4 | 4 | 9 | 4 | 7 |
| EPS | 1.82 | 20.33 | 16.85 | 10.94 | 7.52 | 8.80 | 9.86 | 13.41 | 6.72 | 7.89 | 4.75 | 4.73 | 10.59 | 4.19 | 7.77 |
Hester Biosciences Cash Flow Screener - Liquidity Fundamentals
Screen HESTERBIO cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 65 | 48 | 24 | 9 | 58 | 37 | 47 | 38 | 35 | 19 |
| Investing Activities | -20 | -23 | -77 | -117 | -42 | -73 | -21 | -26 | -30 | -13 |
| Financing Activities | -52 | -26 | 42 | 112 | -18 | 19 | 3 | -11 | 2 | -7 |
| Net Cash Flow | -7 | 0 | -12 | 4 | -2 | -17 | 28 | 1 | 6 | -1 |
Hester Biosciences Shareholding Pattern Screener
See Hester Biosciences shareholding pattern with promoter, FII, and DII holdings.
Check Hester Biosciences promoter holding and ownership changes for HESTERBIO on TickJournal.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 53.73% | 53.73% | 53.73% | 53.73% | 53.73% | 53.73% | 53.73% | 53.73% |
| FII Holding | 0.87% | 0.52% | 0.53% | 0.51% | 0.43% | 0.52% | 0.61% | 0.59% |
| DII Holding | 0.02% | 0.02% | 0.00% | 0.01% | 0.00% | 0.00% | 0.02% | 0.02% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 32.64% | 32.80% | 32.92% | 33.06% | 33.32% | 32.63% | 32.67% | 32.68% |
| Other Holding | 12.73% | 12.93% | 12.82% | 12.68% | 12.52% | 13.12% | 12.97% | 12.97% |
| Shareholder Count | 11,853 | 11,810 | 12,260 | 12,603 | 12,844 | 11,305 | 11,538 | 11,473 |
Hester Biosciences Share Dividend Screener - Share Yield Analysis
Check Hester Biosciences dividend history with payout and yield data.
View Hester Biosciences dividend details including ex-dates and amounts for HESTERBIO stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹7.00 | 0.45% |
| 2024-March | ₹6.00 | 0.48% |
| 2023-March | ₹8.00 | 0.57% |
| 2022-March | ₹10.00 | 0.64% |
| 2021-March | ₹10.00 | 0.37% |
| 2020-March | ₹6.60 | 0.34% |
| 2019-March | ₹11.00 | 1.20% |
| 2018-March | ₹10.00 | 0.65% |
| 2017-March | ₹5.30 | 0.33% |
Hester Biosciences Stock Index Membership
See which indices include Hester Biosciences stock.
Check HESTERBIO index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Hester Biosciences Market Events Screener - Corporate Actions
Get Hester Biosciences corporate actions including splits, bonuses, and buybacks.
Check Hester Biosciences stock events that may affect HESTERBIO share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Dividend | ₹ 8.00 /share | -5.18% | ||
| 2026-01-30 | 2026-01-30 | Quarterly Result Announcement | NA | 1.41% |
| 2025-11-12 | 2025-11-12 | Quarterly Result Announcement | NA | 0.69% |
| 2025-08-13 | 2025-08-13 | Annual General Meeting | NA | 7.94% |
| 2025-08-06 | 2025-08-06 | Dividend | ₹ 7.00 /share | 19.29% |
| 2025-08-01 | 2025-08-01 | Quarterly Result Announcement | NA | 3.70% |
| 2025-05-09 | 2025-05-09 | Quarterly Result Announcement | NA | -4.77% |
| 2025-01-30 | 2025-01-30 | Quarterly Result Announcement | NA | -4.79% |
| 2024-10-28 | 2024-10-28 | Quarterly Result Announcement | NA | -8.20% |
| 2024-08-29 | 2024-08-29 | Annual General Meeting | NA | -22.24% |
| 2024-08-22 | 2024-08-23 | Dividend | ₹ 6.00 /share | 52.21% |
| 2022-08-11 | 2022-08-12 | Dividend | ₹ 10.00 /share | -1.86% |
| 2021-08-05 | 2021-08-07 | Dividend | ₹ 10.00 /share | -14.97% |
Hester Biosciences Competitors Screener - Peer Comparison
Screen HESTERBIO competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 408,007 | 37.20 | 54,729 | 9.71% | 10,980 | 53.25 |
| Divis Laboratories | 163,250 | 66.07 | 9,712 | 18.67% | 2,191 | 48.15 |
| Torrent Pharmaceuticals | 144,229 | 64.43 | 11,539 | 6.99% | 1,911 | 70.35 |
| Cipla | 109,566 | 23.71 | 28,410 | 7.12% | 5,291 | 45.95 |
| Dr Reddys Laboratories | 105,948 | 19.16 | 33,741 | 16.73% | 5,725 | 58.53 |
| Lupin | 101,478 | 21.52 | 22,910 | 13.74% | 3,306 | 60.82 |
| Zydus Life Science | 91,613 | 18.12 | 23,511 | 18.55% | 4,615 | 52.96 |
| Mankind Pharma | 86,000 | 47.17 | 12,744 | 20.90% | 2,007 | 45.43 |
| Aurobindo Pharma | 68,802 | 19.14 | 32,346 | 9.43% | 3,484 | 51.95 |
| Alkem Laboratories | 65,528 | 26.80 | 13,458 | 3.70% | 2,216 | 40.44 |
Hester Biosciences Company Announcements - News Screener
Screen HESTERBIO latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-02-05 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2026-02-04 | Shareholder Meeting / Postal Ballot-Notice of Postal Ballot | View |
| 2026-02-02 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | View |
| 2026-01-31 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2026-01-30 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | View |
| 2026-01-30 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | View |
| 2026-01-30 | Financial Results For The Period Ended 31 December 2025 | View |
| 2026-01-30 | Board Meeting Outcome for Outcome Of Board Meeting Held On 30 January 2026 | View |
| 2026-01-24 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | View |
| 2026-01-23 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | View |
| 2026-01-21 | Board Meeting Intimation for Financial Results | View |
| 2026-01-08 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-12-30 | Closure of Trading Window | View |
| 2025-11-20 | Intimation Under Regulation 30(5) Of The SEBI (LODR) Regulations 2015 | View |
| 2025-11-20 | Announcement under Regulation 30 (LODR)-Change in Management | View |
| 2025-11-20 | Outcome Of Resolutions Passed By The Board Of Directors By Circulation | View |
| 2025-11-14 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | View |
| 2025-11-13 | Resignation Of Chief Financial Officer (CFO) | View |
| 2025-11-13 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-11-12 | Intimation Regarding Speech Of Executive Director At Q2 & H1 FY2025-26 Earnings Conference Call | View |